盐酸氨溴索超声雾化吸入在小儿肺炎患者治疗中的应用效果分析

Analysis of Application Effect in the Treatment of Pediatric Patients With Pneumonia in the Mucosolvin Ultrasonic Atomizing Inhalation

目的：探究盐酸氨溴索超声雾化吸入治疗小儿肺炎的临床效果及价值。方法随机在我院在2013年2月-2014年9月收治的小儿肺炎患者中抽取50例，根据其入院时间的先后，平均分为观察组与对照组，两组各有25例患者。观察组的患者在接受治疗的过程中，使用的药物为盐酸氨溴索联合抗生素；对照组的患者使用的药物为α-糜蛋白酶联合抗生素，两组患者的用药方法均为超声雾化吸入治疗。对比两组患者的疗效及治疗后的相关指标。结果观察组的患者接受治疗后，其治疗的总有效率为100%高于对照组的92%（P＜0.05），分析两组患者的数据，观察组患者的各项指标优于对照组（P＜0.05）。结论小儿肺炎的患者在接受治疗的过程中，采用盐酸氨溴索超声雾化吸入治疗，可以明显的改善患者的身体状况，有效的缓解病情。

ObjectiveExplore the Mucosolvin ultrasonic atomizing inhalation clinical efifcacy and value of treatment of pediatric pneumonia. Methods Extract patients with pediatric pneumonia in February 2013 - 2014 September were 50 cases were selected in our hospital, according to the time of admission were successively, the average score as the observation group and control group, two groups each of 25 patients. In the observation group, the patients in the treatment process, the drug use ambroxol combined with antibiotics, the control group of patients using the drug for alpha chymotrypsin in combination with antibiotics, medication method of two groups of patients were ultrasonic atomizing inhalation in the treatment.ResultsThe patients in the observation group after treatment, the treatment of total efifciency was 100%, higher than the control group of 92% （P〈0.05）, analysis of data of two groups of patients, the observation group of patients with the indicator is better than the control group （P〈0.05）. Conclusion Pediatric pneumonia patients in treated by ambroxol ultrasound atomization inhalation treatment, can significantly improve the patient＇s physical condition, to effectively alleviate the illness.